Inactive Instrument

News Centessa Pharmaceuticals plc Deutsche Boerse AG

Stocks

260 US1523091007

Biotechnology & Medical Research

All News

06-23	Centessa Pharmaceuticals plc(NasdaqGM:CNTA) dropped from NASDAQ Composite Index	CI
06-23	Centessa Pharmaceuticals plc(NasdaqGS:CNTA) dropped from NASDAQ Biotechnology Index	CI
06-23	Eli Lilly and Company completed the acquisition of Centessa Pharmaceuticals plc from Medicxi Ventures (UK) LLP, Index Ventures SA, General Atlantic Service Company, L.P. and other shareholders.	CI
06-22	Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales	GL
06-22	Centessa Pharmaceuticals plc(NasdaqGS:CNTA) dropped from S&P Global BMI Index	CI
05-11	Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA	BU
05-05	Centessa Pharmaceuticals plc Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-20	Wells Fargo Downgrades Centessa Pharmaceuticals ADR to Equal Weight From Overweight, Adjusts Price Target to $42 From $35	MT
04-01	B. Riley Downgrades Centessa Pharmaceuticals to Neutral From Buy, Lifts Price Target to $45 From $42	MT
04-01	Leerink Partners Downgrades Centessa Pharmaceuticals to Market Perform From Outperform, $36 Price Target	MT
04-01	Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA	BU
03-31	Centessa Pharmaceuticals plc Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-31	Are APLS, CNTA, BIRD Obtaining Fair Deals for their Shareholders?	PR
03-31	Eli Lilly and Company entered into a definitive agreement to acquire Centessa Pharmaceuticals plc from a group of shareholders for $5.1 billion.	CI
03-31	CNTA Stock Alert: Halper Sadeh LLC is Investigating Whether Centessa Pharmaceuticals plc is Obtaining a Fair Price for its Shareholders	BU
03-31	Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders	PR
03-30	Centessa Pharmaceuticals Insider Sold Shares Worth $1,237,382, According to a Recent SEC Filing	MT
03-27	Centessa Pharmaceuticals Insider Sold Shares Worth $719,940, According to a Recent SEC Filing	MT
03-19	Centessa Pharmaceuticals Insider Sold Shares Worth $2,109,180, According to a Recent SEC Filing	MT
03-16	Centessa Pharmaceuticals Insider Sold Shares Worth $1,927,131, According to a Recent SEC Filing	MT
03-16	Centessa Pharmaceuticals Insider Sold Shares Worth $3,150,673, According to a Recent SEC Filing	MT
02-12	Centessa Pharmaceuticals : February 2026 Corporate Overview (597223)	PU
02-04	Centessa Pharmaceuticals Insider Sold Shares Worth $1,004,918, According to a Recent SEC Filing	MT
02-03	Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences	GL
02-03	Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences	AQ